Monocyte to macrophage differentiation (MDM)

Monocyte to macrophage differentiation is a fundamental biological process in which circulating monocytes migrate into tissues and mature into macrophages, a transition essential for innate immunity and tissue homeostasis (Nature Reviews Immunology, 2015). This process is primarily regulated by the Colony-stimulating factor 1 receptor (CSF1R), a tyrosine kinase receptor that, upon binding its ligands M-CSF or IL-34, initiates signaling cascades and transcriptional changes involving factors like PU.1 (UniProt, 2024). The maturation process is characterized by the loss of monocyte markers like CD14 and the gain of macrophage-specific proteins such as CD68 and CD163 (Journal of Leukocyte Biology, 2014). In pathological states such as cancer, this differentiation is often skewed toward immunosuppressive phenotypes, resulting in tumor-associated macrophages (TAMs) that facilitate tumor progression and therapy resistance (Cell, 2011). Therapeutic strategies targeting this process focus on inhibiting CSF1R or its ligands to deplete or reprogram macrophage populations in the tumor microenvironment or in chronic inflammatory conditions (Journal of Clinical Oncology, 2019). While these interventions show promise, they are associated with safety concerns including myelosuppression and hepatotoxicity due to the role of macrophages in normal physiological functions (FDA, 2019).

Other names

Monocyte-to-macrophage transitionMacrophage maturationMonocyte-derived macrophage differentiation

Inhibition of the Colony-stimulating factor 1 receptor (CSF1R) signaling pathway, which is the primary driver of monocyte survival and differentiation into macrophages (Nature Reviews Immunology, 2015).